USPTO serial 79394877
TETRATHERIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 17, 2025
- Examiner
- SALCIDO, JOHN CHARLES
- Law office
- Historical data usage
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with TETRATHERIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey P. Dunning
Jeffrey P. Dunning Greenberg Traurig, LLP77 W. Wacker DriveSuite 3100Chicago, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations for the repair of damaged tissue and tissue regeneration; chemical preparations for medical purposes, namely, for the repair of damaged tissue and tissue regeneration; chemical preparations for pharmaceutical purposes, namely, for the repair of damaged tissue and tissue regeneration; chemical products for medical use for the repair of damaged tissue and tissue regeneration; chemical reagents for use in medicine; chemical test reagents for medical purposes; chemicals having antimicrobial properties for medical purposes, namely, for the repair of damaged tissue and tissue regeneration; diluents for medical use being fully synthetic biomaterial for use in the repair of damaged tissue and tissue regeneration; injectable solutions for medical purposes, namely, for the repair of damaged tissue and tissue regeneration; polymer coatings for medical use, namely, for the repair of damaged tissue and tissue regeneration; sprays for use on the body being medicaments for use in connection with the repair of damaged tissue and tissue regeneration; sterilising solutions; sterilising preparations; surgical adhesives for the repair of damaged tissue and tissue regeneration; synthetic resins for surgical and medical use, namely, for the repair of damaged tissue and tissue regeneration; anti-viral agents being antivirals; biochemical preparations for medical use, namely, for the repair of damaged tissue and tissue regeneration; bone cement for surgical and orthopaedic use; anaesthetic preparations, namely, anesthetics for surgical and non-surgical use * ; all of the aforementioned being for human and none of the aforementioned being for pets * | ACTIVE | — |
| 010 | Medical and surgical devices, namely, devices for the repair of damaged tissue and tissue regeneration; medical apparatus and instruments, namely, apparatus and instruments for the repair of damaged tissue and tissue regeneration, and surgical apparatus and instruments; medical grafts, namely, synthetic bone grafts, synthetic stent grafts, artificial vascular grafts; surgical graft material, namely, synthetic media for use in the augmentation of bone and tissue for medical purposes; medical syringes; orthopaedic articles, namely, orthopaedic implants made of artificial materials; evaporators for liquid anaesthetics, namely, anaesthetic inhalers, sold empty; chemical analysers being apparatus for medical use, namely, medical diagnostic instruments for the analysis of body fluids; * computer apparatus for use in * monitoring [ instruments for ] biochemical reactions for medical * use * [ purposes, to be used with computer apparatus, ] namely, medical instruments for monitoring vital signs, blood properties and respiratory events; hand-operated hand sprayers, for medical use, namely, sprayers for application of chemical preparations during medical procedures; power-operated sprayers for medical use, namely, sprayers for application of chemical preparations during medical procedures | ACTIVE | — |
| 042 | Scientific research including in the field of material science; chemical research; medical research; medical research laboratory services; design of medical apparatus | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Trimph Pty Limited
- Other trademarks owned by Trimph Pty Limited
- Other trademarks owned by Trimph Pty Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named TETRATHERIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 5, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 3, 2026 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jan 15, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 15, 2026 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jan 15, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 14, 2026 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jan 14, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 18, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 2, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 2, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Sep 17, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 17, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 17, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 18, 2025 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 1, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 25, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 20, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 20, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 20, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 8, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 8, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 1, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 14, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 14, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 2, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |